Sign Up To Receive Pure Extracts Corporate Presentation
A Leader in Extraction
Pure Extracts is positioned to be the dominant extraction company to rapidly develop and commercialize both cannabis and functional mushroom products.
The mushroom extraction market is driven by research and development activity focused on depression, PTSD, anxiety, bi-polar disorder, drug and alcohol dependence, obesity, narcolepsy, OCD, Alzheimer's disease and ADHD.
Core Areas of Focus
Research & Development
Five years of experience with volatile plant molecule extraction and existing tolling agreements in place.
Advisory Agreement with Dr. Alexander MacGregor, Founder of Transpharm Canada Inc. and the Toronto Institute of Pharmaceutical Technology, one of North America’s premier post-graduate institutes of pharmaceutical sciences, technology and research.
Experience creating multiple successful CPG products and brands with its existing Pure Pulls brand name.
Facility Built for EU GMP Certification
Centralized facility for proprietary and white-labeled production.
The cutting-edge facility features:
10,000 sq. ft. at current facility.
Phase II expansion plans under development to reach 25,000 sq. ft.
Building to EU-GMP standards for international distribution.
Dedicated lab and packaging spaces.
Applying for Natural Health Products Site License, followed with submitting a Product License application for specific functional products.
Modern CO2 and ethanol extraction capabilities and processes.
Designed with growth in mind. Easily scalable.
Download the Investor Presentation& Learn How to Invest